Long-term risks are rare but may include nerve damage, leading to tingling, numbness, or weakness in limbs
However, it is noteworthy that ten oligonucleotide drugs have been officially approved by FDA as of January 2020 [55], which means that the technological obstacles for oligonucleotide therapeutics are being solved step by step and the development of oligonucleotide drugs targeting NNMT is still a promising method for the prevention or treatment of obesity and related T2D in the future
Not classified as drugs, supplements, or food, and not evaluated by the FDA for diagnosis, treatment, cure, or prevention of any condition
We will answer the top 10 questions people have about these treatments, providing you with the information you need to make an informed decision about your weight loss journey
We work closely with each patient to develop realistic and achievable goals that fit their lifestyle and long-term health objectives